Price
No data yet.
Signal Score (90d)
80Revenue
$4.06B+30.40%Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $12.48B | $509.00M | $3.80 |
| 2024 | $12.63B | $-516.00M | $-3.90 |
| 2023 | $12.49B | $-133.00M | $-1.02 |
| 2022 | $12.21B | $46.00M | $0.36 |
| 2021 | $12.37B | $230.00M | $1.82 |
Social Signal Score
Earnings
Thu, Oct 22(in 2 months)
Consensus estimate $-0.29 per share
Typical surprise -83.4% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 22$-0.19 vs $-0.10miss
- Tue, Apr 21$-0.48 vs $-0.11miss
- Wed, Feb 18$-0.01 vs $-0.20beat
- Thu, Oct 23$1.27 vs $-0.28beat
- Wed, Jul 23$-0.05 vs $0.05miss
- Wed, Apr 23$-0.03 vs $-0.10beat
Estimates and results for CYH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CYH officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CYH's reported EPS growth of 20.2% a year over 4 years.
- EPS in 5 years
- $9.53
- Implied price
- $171.56
- Return from $2.96
- 125.3% a year
To earn 15.0% a year on these assumptions you'd need to buy at $85.29 — today's price is already 96.5% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| 10.2% | 90.5% | 99.2% | 106.6% | 113.0% | 118.8% |
| 15.2% | 99.1% | 108.2% | 115.9% | 122.7% | 128.7% |
| 20.2% | 107.8% | 117.2% | 125.3% | 132.4% | 138.6% |
| 25.2% | 116.4% | 126.3% | 134.7% | 142.0% | 148.6% |
| 30.2% | 125.0% | 135.3% | 144.0% | 151.7% | 158.5% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (1)
- Newszacks.com·5h ago·Negative
Community Health Trades at a Deep Discount to Peers: Hold or Fold? CYH trades at a deep discount to peers as acquisitions, cost control and debt reduction progress, but cash flow remains a concern.
View source ↗